Highlights Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Market Closed - Xetra Other stock markets 12:41:29 13/12/2025 am IST			5-day change	1st Jan Change
5.246 ^EUR	-0.27%		-3.32%	-35.99%

09/12	Sources: Novo Nordisk Group Holding reduces stake in Evotec	DP
09/12	Evotec secondary ABB priced at EUR 5.10 per share, bookrunner says	RE

Highlights

Sandoz Concludes Purchase of Evotec's Biologics Platform	08/12	MT
Sandoz completes strategic acquisition of Just-Evotec Biologics EU SAS, asserting biosimilars leadership	08/12	RE
Novo Holdings Reportedly Plans to Sell 9.4 Million Shares in Evotec	08/12	CI
Sandoz Group AG completed the acquisition of Just-Evotec Biologics EU SAS from Evotec SE.	05/12	CI
Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome	04/12	CI
Evotec SE Starts Phase 2 Study for Treatment of Patients with Alport Syndrome	04/12	CI
Sector Update: Health Care Stocks Higher in Afternoon Trading	13/11	MT
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Hopes of Federal Government Reopening	12/11	MT
Evotec SE - to implement share repurchase program	06/11	RE
Evotec SE announces an Equity Buyback for 290,000 shares, for ?3 million.	06/11	CI
Evotec SE authorizes a Buyback Plan.	06/11	CI
Analyst recommendations: Nvidia, Tesla, IBM, AMD, Amgen…	05/11
Evotec SE Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	05/11	CI
Evotec SE Confirms Earnings Guidance for the Full Year 2025	05/11	CI
Evotec Q3 Loss Widens, Revenue Falls; Shares Down Pre-Bell	05/11	MT
Evotec Disappoints in Third Quarter - Sells JEB to Sandoz	05/11	DP
Evotec Set for Windfall from Sale of Toulouse Plant to Sandoz	05/11	RE
Evotec Widens Operating Loss, Division Sale Boosts Share Price	05/11	DP
Evotec to Sell Just - Evotec Biologics EU, Site in France to Sandoz	05/11	MT
Evotec Secures $25 Million Funding Under Bristol Myers Squibb Neuroscience Partnership	27/10	MT
Evotec receives $25 mln payment from Bristol Myers Squibb to support joint programs	27/10	RE
Evotec SE Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb	27/10	CI
RBC Retains Evotec's Outperform Rating Amid Potential Deal with Sandoz	03/09	MT
Evotec falls after figures	13/08	DP
Evotec SE Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	13/08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Highlights

Filters